Fermenta Biotech inaugurates customized premix manufacturing plant in Kullu, Himachal Pradesh
The company will develop and produce premixes for human nutrition applications
The company will develop and produce premixes for human nutrition applications
The company has entered into a three-year Deferred Prosecution Agreement
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
The net profit in the June quarter was also lower than Rs 146.3 crore reported in the March quarter.
The agreement extends the customer's suite of cloud DevOps, data engineering, and data platform management solutions
Cipla has a robust governance model focused on sustainability
The company will supply materials to all global regions including Asia such as China, India, Europe, and the U.S.
Subscribe To Our Newsletter & Stay Updated